Marquee Background
Marquee Background

Offit Kurman Blogs

Healthcare

Are Anti-Aging Claims Drug Claims or Cosmetics Claims?

August 8, 2023

By Michael H. Cohen

In today’s video, we focus on anti-aging products to determine whether FDA will likely regard your product as a drug instead of a cosmetic, which where you wanted to be.

Hi, I’m Michael H. Cohen, founding attorney of Cohen Healthcare Law Group. It’s a sunny day, it’s really me, and the glasses are photogray. We’ve helped lots of clients just like you, navigate the health and wellness industry through the legal requirements.

Let’s talk about the Intended Use Doctrine.  FDA determines that the intended use of a product could make it a drug, it looks to the labeling. And “labeling,” under the federal Food, Drug & Cosmetic Act (FDCA) will mean “all labels and other written, printed, or graphic matter (1) on any article or any of its containers or wrappers, or (2) accompanying such article.” In other words, “labeling” includes everything on the website, such as the blog, the product name, all the marketing.

Everything is “labeling.”

Worse (for you), this “intended use” doctrine gives FDA broad enforcement discretion.  FDA can look at everything you’ve put out about the product and say, hey, this sounds like a drug to us. That’s the intended use, gleaned from the totality of the contents.

Next, FDA gives particular scrutiny to some kinds of products, for example, Weight loss.  The market is flooded with weight loss products whose claims go too far, and if you get to the end of this video, I guarantee you’ll lose two inches off your waist! That is, if you simultaneously engage in caloric restriction, read the fine print please.

Okay, weight loss products, big problems for the FDA and the FTC.

Now, you can’t look to what other companies are doing as evidence that they are successfully beyond enforcement scrutiny.  Lots of people out there, not everyone gets caught. People are doing things, sometimes it takes years, but it can happen and it does happen.

So, enough about weight, let’s talk about wrinkles.  And there are some fine lines here, pardon the pun.  If a product is intended to make lines and wrinkles less noticeable, simply by moisturizing the skin, the FDA will likely regard the product as a cosmetic. Similarly, makeup or “primers” intended to make the signs of aging less noticeable just by hiding them, are also considered, cosmetics.

But products intended to affect the structure or function of the body, such as skin, are regulated as drugs.  Note, if they’re not applied topically to the skin, and are machines, they might be considered medical devices. So, for example, if a product is intended to remove wrinkles or increase the skin’s production of collagen, it’s likely a drug or a medical device.

Put another way, FDA emphasizes that products that are merely “intended to make people more attractive” generally are cosmetics.  FDA states that its concern is with claims “that involve supposed effects on the structure of function of the skin.” Sound familiar? That’s part of the definition.

Remember that drugs and medical devices are much more expensive to bring to market, and the regulatory burden is much higher, so it’s better if you can tame your claims to keep your product in the regulatory bucket of a cosmetic—assuming you can do this without sacrificing too much marketing power.

And that’s where legal strategy comes in, as FDA lawyers we enjoy working with language, our goal is to help you choose marketing claims that won’t likely make the FDA bull charge at you, yet will also waive the flag sufficiently for marketing so that you’ll gain market share.

Along these lines, we’d like to refer you to other materials on our Healthcare & FDA blog that talk about ten ways you can unwittingly end up making an implied disease claim for your product.

Thanks for watching. Please contact us with your questions, comments. We have helped hundreds, thousands of healthcare companies just like you, market their products, navigate the legal and regulatory boundaries.  We look forward to working with you on the journey to your success!

This content is unavailable due to your cookie consent preferences.

Click here to adjust your preferences.

Testimonials

Categories: Healthcare

Related People

Related Services

  • Posts
  • About
  • Subscribe

Firm Highlights

  • Events
    AIA Tri-State Conference
    Princeton will serve as the backdrop for three days of connection, learning, and design leadership. From keynotes to tours to the Tri-State Design Awards, this year’s conference is designed to go far beyond education sessions. Kick off the week with pre-conference intensives and individual state component Design Award celebrations, followed by three days of education, inspiration, networking, and design excellence at the 2026 AIA Tri-State Conference—featuring pre-conference intensives, three keynote speakers, 25 education sessions, curated tours, an expo, spec academies, and the AIA Tri-State Design Awards—bringing together architects and design professionals from New Jersey, New York, and Pennsylvania to connect, learn, and celebrate the best of the profession. G2. Designing Secure Practices: Cybersecurity, Data Privacy, Contractual Provisions, and Insurance Risks for Architects (4:00 PM - 5:30 PM) Architects and design professionals increasingly rely on cloud platforms, BIM software, and digital tools to manage sensitive data, creating cybersecurity and privacy risks. A single incident can trigger liability claims, regulatory obligations, reputational harm, and insurance challenges. Yet many firms underestimate how contracts, insurance, and internal practices intersect during a breach. This program offers legal and insurance perspectives on cyber risk in architecture, examining liability exposure, risky contract provisions, and mitigation strategies. A cyber insurance expert will explain policy responses, coverage gaps, coordination with professional liability, and best practices for aligning insurance with contractual risk and protecting firms from evolving cyber threats. Learning Objectives: Identify key cybersecurity and data privacy risks faced by architecture firms and explain how these risks can impact professional liability and project outcomes. Analyze common contractual provisions to determine which clauses may increase exposure to cyber incidents and propose strategies to mitigate these risks. Evaluate the scope and limitations of cyber insurance policies, including coordination with professional liability coverage, to determine how a policy would respond in a breach scenario. Develop actionable risk management strategies by integrating legal, contractual, and insurance considerations to protect sensitive client and project data.
  • Events
    The 2026 Economic, Tax, and Accounting Updates
    We are looking forward to the Mid-Atlantic CFO Roundtable's next event on November 13, 2026. This is a program with topics built for Finance Executives. We are extremely fortunate to have three excellent speakers: Dr. Daraius Irani, Vice President of Business and Public Engagement at Towson University; Mike Stankus, Tax Office Managing Principal at BDO; and Daniel Wahlberg, Managing Partner of Acclare Solutions. The economy is rapidly changing with various factors driving it. The November 3rd midterm elections may also have an impact. Our three expert presenters will discuss the ramifications of the election, and the current year updates to GAAP financial reporting and Federal and State income taxes. Please join us for what will surely be an informative and timely discussion. Meet Our Speakers: Daraius Irani, Ph.D. • Towson University Vice President, Business & Public Engagement Dr. Daraius Irani serves as Vice President of Business and Public Engagement at Towson University as well as the chief economist for the Regional Economic Studies Institute (RESI) at Towson University, a policy group providing economic, fiscal impact, and policy analysis to public and private entities.  Dr. Irani is often called upon to provide economic presentations to organizations across Maryland. He has appeared on numerous television programs and in local and regional print media. Dr. Irani holds a Ph.D. in economics from University of California, Santa Barbara. Dan Wahlberg • Acclare Solutions Managing Partner With over 28 years of experience, Dan Wahlberg is a recognized leader in audit and assurance for the Mid-Atlantic’s middle market business community. As a licensed CPA in Maryland and Virginia, Dan has led assurance practices at top regional firms, including serving as Baltimore Audit Managing Partner and Assurance Practice Leader at BDO USA in Baltimore and as Partner and member of the Management Committee at Hertzbach & Company P.A which merged into BDO in 2020. His expertise centers on delivering clarity, strategic guidance, and proactive solutions to middle-market businesses across Baltimore and beyond. His entrepreneurial spirit has led him to begin a new CPA firm this year with four other CPAs serving the business community. Dan holds a Bachelor of Science in Accounting from Rutgers University and began his career at PWC in New York. He is also deeply engaged in the community, previously serving as President of ACG Maryland and current Board member and as Audit Committee Member for The Associated: Jewish Federation of Baltimore.  Mike Stankus • BDO USA LLP Tax Office Managing Principal Mike Stankus is the Tax Office Managing Principal for the firm’s Baltimore office. He has more than 16 years of experience providing tax planning and preparation and management advisory services for his clients. Mike focuses on advising privately held businesses and their owners on effective growth and tax strategies. He also performs various engagements for mergers and acquisitions and complex cost accounting projects and projections. In addition, he represents various government contracting clients before the DCAA and assists with FAR compliance. Mike’s areas of concentration include working with government contractors, professional service firms, construction companies, and homebuilders.